Recruiting

Coronary Interventions

Sponsor:

Olivier F. Bertrand

Code:

NCT06972225

Conditions

Coronary Arterial Disease (CAD)

Restenosis, Coronary

Bifurcation Coronary Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DEB

Study Details

Brief summary:

Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.

Conditions

Coronary Arterial Disease (CAD)

Restenosis, Coronary

Bifurcation Coronary Disease

Study ID

NCT06972225

Start date

Jun 10, 2025

Status verified date

Apr, 2026

Completion date

Mar, 2036

Anticipated

Primary completion date

Dec, 2035

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adults (>=18 years of age)
  • Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025
  • Identified in the institutional procedure database

Exclusion Criteria:

  • Incomplete or non-available data on the post-procedural clinical follow-up
  • Procedures where other devices were used in combination with drug-eluting balloons.

Study Design

Enrollment

1500 participants

Anticipated

Interventions and Outcome Measures

Arms

DEB

Interventions

DEB

Use of DEB to treat coronary lesions

Primary outcome measure

  • Major Adverse Cardiovascular Events [ Time Frame: within 10 years of inclusion ]

Central Contacts and Locations

Central contacts

Michele Jadin

418-6568711michele.jadin@criucpq.ulaval.ca

Locations

IUCPQ

Recruiting

Québec, Quebec, Canada, G1V4G5

Contacts

Michele Jadin

418-656-8711michele.jadin@criucpq.ulaval.ca

Principal Investigator:

Olivier F. Bertrand, MD, PhD

More Information

Sponsor

Olivier F. Bertrand

Last update posted

Apr 20, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Olivier F. Bertrand on 2026-04-20.